ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xue Yang, Zhi-Jie Xu, Xi Chen, Shuang-Shuang Zeng, Long Qian, Jie Wei, Mei Peng, Xiang Wang, Wan-Li Liu, Hong-Ying Ma, Zhi-Cheng Gong and Yuan-Liang Yan |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
the National Natural Science Foundation of China |
81803035, 81703036, 81572946 |
the China Postdoctoral Science Foundation |
2017M610510 |
Youth Fund of Xiangya Hospital |
2017Q17 |
the Postdoctoral Science Foundation of Central South University |
185702 |
|
Corresponding Author |
Zhi-Cheng Gong, PhD, Academic Fellow, Chief Pharmacist, Professor, Department of Pharmacy, Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, Hunan Province, China. gongzhicheng@csu.edu.cn |
Key Words |
Methylated septin 9; Methylated; Colorectal cancer; Diagnosis; Prognosis |
Core Tip |
This study retrospectively explored the value of serum septin 9 methylation (mSEPT9) in the diagnosis and prognosis of colorectal cancer in a Chinese population. Preoperative mSEPT9 levels in 354 enrolled patients were retrospectively analyzed. In addition, the effects of mSEPT9 on the occurrence and prognosis of 330 colorectal cancer cases from The Cancer Genome Atlas database were evaluated using bioinformatics analyses. Besides, nine meaningful mSEPT9 sites were found to provide guidance for the follow-up studies. |
Publish Date |
2019-05-06 02:06 |
Citation |
Yang X, Xu ZJ, Chen X, Zeng SS, Qian L, Wei J, Peng M, Wang X, Liu WL, Ma HY, Gong ZC, Yan YL. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients. World J Gastroenterol 2019; 25(17): 2099-2109 |
URL |
https://www.wjgnet.com/1007-9327/full/v25/i17/2099.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v25.i17.2099 |